Letter: Rifaximin Versus Low FODMAP Diet in IBS: What the Primary Endpoint Does Not Tell Us. Authors' Reply

Aliment Pharmacol Ther. 2026 Mar;63(6):909-910. doi: 10.1111/apt.70553. Epub 2026 Jan 29.
No abstract available

Publication types

  • Letter